|
Name |
Integracide B
|
Molecular Formula | C32H50O5 | |
IUPAC Name* |
[(2R,3R,5R,10S,11R,12R,13R,17R)-2,3,11-trihydroxy-4,4,10,13-tetramethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-1,2,3,5,6,7,11,12,16,17-decahydrocyclopenta[a]phenanthren-12-yl] acetate
|
|
SMILES |
C[C@H](CCC(=C)C(C)C)[C@H]1CC=C2[C@@]1([C@H]([C@@H](C3=C2CC[C@@H]4[C@@]3(C[C@H]([C@@H](C4(C)C)O)O)C)O)OC(=O)C)C
|
|
InChI |
InChI=1S/C32H50O5/c1-17(2)18(3)10-11-19(4)22-13-14-23-21-12-15-25-30(6,7)28(36)24(34)16-31(25,8)26(21)27(35)29(32(22,23)9)37-20(5)33/h14,17,19,22,24-25,27-29,34-36H,3,10-13,15-16H2,1-2,4-9H3/t19-,22-,24-,25+,27-,28+,29+,31+,32-/m1/s1
|
|
InChIKey |
VCOKSAAKIDFNQE-PGHPLGCHSA-N
|
|
Synonyms |
Integracide B; CHEMBL464128; SCHEMBL4742500; BDBM50250713; [(2R,3R,5R,10S,11R,12R,13R,17R)-2,3,11-trihydroxy-4,4,10,13-tetramethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-1,2,3,5,6,7,11,12,16,17-decahydrocyclopenta[a]phenanthren-12-yl] acetate; [(2R,3R,5R,10S,11R,12R,13R,17R)-17-[(1R)-1,5-dimethyl-4-methylene-hexyl]-2,3,11-trihydroxy-4,4,10,13-tetramethyl-1,2,3,5,6,7,11,12,16,17-decahydrocyclopenta[a]phenanthren-12-yl] acetate; 24-Methylene-30-nor-5alpha-lanostane-8,14-diene-2alpha,3beta,11beta,12alpha-tetrol 12-acetate; Ergosta-8,14,24(28)-triene-2,3,11,12-tetrol, 4,4-dimethyl-, 12-acetate, (2.alpha.,3.beta.,5.alpha.,11.beta.,12.alpha.)-
|
|
CAS | NA | |
PubChem CID | 503621 | |
ChEMBL ID | CHEMBL464128 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 514.7 | ALogp: | 5.6 |
HBD: | 3 | HBA: | 5 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 87.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 37 | QED Weighted: | 0.305 |
Caco-2 Permeability: | -5.053 | MDCK Permeability: | 0.00001390 |
Pgp-inhibitor: | 0.997 | Pgp-substrate: | 0.164 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.376 |
30% Bioavailability (F30%): | 0.671 |
Blood-Brain-Barrier Penetration (BBB): | 0.002 | Plasma Protein Binding (PPB): | 95.39% |
Volume Distribution (VD): | 1.482 | Fu: | 3.03% |
CYP1A2-inhibitor: | 0.035 | CYP1A2-substrate: | 0.097 |
CYP2C19-inhibitor: | 0.029 | CYP2C19-substrate: | 0.813 |
CYP2C9-inhibitor: | 0.224 | CYP2C9-substrate: | 0.419 |
CYP2D6-inhibitor: | 0.095 | CYP2D6-substrate: | 0.09 |
CYP3A4-inhibitor: | 0.602 | CYP3A4-substrate: | 0.649 |
Clearance (CL): | 2.779 | Half-life (T1/2): | 0.375 |
hERG Blockers: | 0.293 | Human Hepatotoxicity (H-HT): | 0.341 |
Drug-inuced Liver Injury (DILI): | 0.253 | AMES Toxicity: | 0.015 |
Rat Oral Acute Toxicity: | 0.227 | Maximum Recommended Daily Dose: | 0.921 |
Skin Sensitization: | 0.387 | Carcinogencity: | 0.007 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.015 |
Respiratory Toxicity: | 0.954 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003486 | 1.000 | D0X7XG | 0.288 | ||||
ENC003755 | 0.821 | D0H2MO | 0.278 | ||||
ENC003487 | 0.721 | D0OR2L | 0.273 | ||||
ENC003485 | 0.710 | D03ZTE | 0.268 | ||||
ENC002075 | 0.415 | D0G3SH | 0.268 | ||||
ENC005630 | 0.368 | D0Y7LD | 0.266 | ||||
ENC002718 | 0.353 | D0M4WA | 0.259 | ||||
ENC005968 | 0.348 | D08SVH | 0.250 | ||||
ENC001603 | 0.348 | D0E9KA | 0.241 | ||||
ENC002119 | 0.338 | D09WYX | 0.240 |